
Official Twitter account of UCLA Urology and UCLA Urology Residency. #UCLAUrology @UCLAHealth @UCLA @dgsomucla
Los Angeles, CA
Joined October 2019
- Tweets1.6K
- Following682
- Followers3.7K
- Likes2K
Pinned Tweet
Happy #matchday soon to be Urologists
Congrats to soon-to-be-doctors Bettencourt, Lerman, Borrell, and Yoffe
We look forward to welcoming you to the @UCLAHealth Urology family this summer.
For those who didn't receive the news they hoped for, your journey is still beginning.
UCLA Urology retweeted
It was an honor to give grand rounds today at @UclaUrology
Thanks for the invite and the incredible questions
@uroegg, Dr. Jennifer Singer, @JuanJAndino
UCLA Urology retweeted
Disorders of ejaculation are among the most common male sexual health concerns, yet they often remain underrecognized and undertreated.
Developed by the AUA in partnership with @SMSNA_ORG, the 2026 Disorders of Ejaculation Guideline Amendment provides contemporary recommendations for the evaluation and management of premature and delayed ejaculation, helping clinicians navigate diagnosis, treatment, and patient counseling.
🔗 Click to read the Guideline Amendment: bit.ly/4t0WhUV
CANCER TREATMENT & FERTILITY: WHAT MEN SHOULD KNOW
When a man is diagnosed with cancer, treatment takes priority. But another important question may be overlooked: Will treatment affect his ability to have biological children?
In this excerpt from the Blue Cure Men’s Health Podcast, Juan José Andino, MD, MBA, a UCLA Health urologist and urology lead for UCLA’s Oncofertility Program, explains why fertility preservation matters before treatment.
IMPORTANT DEFINITIONS:
• Oncofertility: A field of medicine focused on protecting reproductive options for people diagnosed with cancer.
• Fertility: The biological ability to have children. Cancer treatment may affect it.
• Cryopreservation: Freezing and storing sperm for possible future use.
• Sperm banking: Collecting and storing sperm before cancer treatment for possible future use.
WHAT MEN AND THEIR PARTNERS SHOULD KNOW:
• Treatment can affect ejaculation and fertility. Radical prostatectomy generally eliminates ejaculation. Radiation can reduce or eliminate semen production, and some cancer treatments can impair sperm production or quality.
• Sperm production and ejaculation are different. Some men may continue producing sperm even when they can no longer ejaculate normally.
• Preservation options have expanded. Dr. Andino discusses sperm banking through fertility clinics and at-home collection services, including Fellow, which may help men facing geographic or insurance barriers.
• Age doesn’t tell the whole story. Although fertility preservation is discussed more often with younger patients, including those with testicular cancer, it can also matter to men diagnosed with prostate cancer later in life.
THE IMPORTANT TAKEAWAY:
If having biological children now or in the future matters to you, ask your medical team about fertility preservation before starting cancer treatment. This conversation matters at any age.
ABOUT OUR GUEST
Juan José Andino, MD, MBA
UCLA Health urologist specializing in male fertility and sexual medicine.
uclahealth.org/providers/jua…
Medical disclaimer: Educational only. Consult your medical team.
Dr @yonibergman represented our department at the @AmerUrological Science & Quality summit
Part of the Finding and Removing Pebbles in the Shoe session - how to use quality improvement to improve care and experience of urologists esp with looming workforce shortages
In a session this morning at the #SQSummit, Jonathan Bergman, MD, MPH, talks about managing the supply and demand mismatch for urologists across the country, using @EugeUrology and @m_e_nielsen as visual examples of how many urologists would be needed to meet demand.
UCLA Urology retweeted
Got texts from former Michigan co residents Russel, @MSLee_MD @AmyLuckenbaugh and policy bestie @RuchikaTalwarMD
@UclaUrology got some shoutouts for being first residency program in country to incorporate #virtualist call model
Idea from @EugeUrology @auawest policy session
UCLA Urology retweeted
In a previous excerpt, UCLA Health urologist Dr. Juan José Andino discussed research on prostate cancer screening disparities among Hispanic men.
In this new video, he shares a message in Spanish about PSA screening, sexual health, and heart health. Please share with a Spanish-speaking family member or friend who could benefit.
UN MENSAJE IMPORTANTE SOBRE LA SALUD DE LOS HOMBRES
¿Cuándo fue la última vez que hablaste con tu médico sobre tu salud?
El Dr. Juan José Andino, urólogo de UCLA Health, comparte dos mensajes importantes para los hombres y sus familias.
1. CÁNCER DE PRÓSTATA: PREGUNTA POR LA PRUEBA DEL PSA
El PSA (antígeno prostático específico) es un análisis de sangre que puede ayudar a detectar el cáncer de próstata antes de que aparezcan síntomas.
El Dr. Andino anima a los hombres a hablar con su médico sobre esta prueba alrededor de los 40 años. La edad adecuada para comenzar depende del riesgo individual, incluidos los antecedentes familiares.
No todos los hombres necesitan hacerse la prueba a la misma edad. Lo importante es tener la conversación y tomar una decisión informada.
2. DISFUNCIÓN ERÉCTIL: UNA POSIBLE SEÑAL DE ALERTA
Los cambios en las erecciones no siempre son solo un problema sexual. En algunos hombres, pueden ser una señal de problemas cardiovasculares.
No tengas pena de hablarlo. Tu médico puede ayudarte a identificar la causa y conocer las opciones de tratamiento.
TU SALUD IMPORTA. DA EL PASO.
Habla con tu médico, haz preguntas y no esperes a tener síntomas para cuidar tu salud.
Comparte este video con tu papá, hermano, esposo, hijo o amigo. Una conversación puede marcar la diferencia.
CONOCE AL ESPECIALISTA
Juan José Andino, MD, MBA
Urólogo de UCLA Health, especializado en salud del hombre y medicina sexual. También atiende a pacientes en el sur de Los Ángeles.
uclahealth.org/providers/jua…
SÍGUENOS PARA APRENDER MÁS
Somos parte de @BlueCure, una organización sin fines de lucro dedicada a la educación sobre el cáncer de próstata y la salud masculina. Descarga gratis nuestra lista “Conoce Tus Números” en español para llevarla a tu próxima cita médica: bluecure.org
Aviso médico: Contenido educativo. No sustituye la consulta médica. Habla con tu médico sobre las pruebas y decisiones adecuadas para ti.
UCLA Urology retweeted
Medicare physician payments have fallen ~33% since 2001 when adjusted for inflation in practice costs.
An AMA-led coalition is calling on Congress to take action with four bipartisan reforms that would support physician practices, strengthen Medicare and protect patients’ access to care. spr.ly/6012ByKW64 #FixMedicareNow
UCLA Urology retweeted
Phenomenal #SQSummit presentation from Jon B on transformational work with urology / primary care collaboration to transform the specialty care delivery model
🚀🚀🚀🚀🚀
👀➡️ jamanetwork.com/journals/jam…
In a session this morning at the #SQSummit, Jonathan Bergman, MD, MPH, talks about managing the supply and demand mismatch for urologists across the country, using @EugeUrology and @m_e_nielsen as visual examples of how many urologists would be needed to meet demand.
UCLA Urology retweeted
In a session this morning at the #SQSummit, Jonathan Bergman, MD, MPH, talks about managing the supply and demand mismatch for urologists across the country, using @EugeUrology and @m_e_nielsen as visual examples of how many urologists would be needed to meet demand.
UCLA Urology retweeted
The American Cancer Society now recommends PSA screening, its first direct call to screen since 2010.
New commentary by @uretericbud: the evidence, the guideline comparison, and why the pathway after the PSA is our job.
urologywatch.com/commentary/…
@AmericanCancer #prostatecancer
UCLA Urology retweeted
After 16 years, @AmericanCancer now directly recommends PSA screening. Stronger evidence of benefit plus better tools to limit overdiagnosis and overtreatment. A welcome, balanced shift.
My take in @PhillyInquirer: share.inquirer.com/yPRmKb
Thoughtful nuanced and individualized care pathway matters most. @fcuroonc @foxchasecancer
UCLA Urology retweeted
🚨 Major shift: @AmericanCancer now directly recommends routine PSA screening for #prostatecancer, moving off pure shared decision-making 🚨
@CACancerJournal
📋 Average risk: PSA every 2 yrs, ages 50-69
📋 High risk (Black men; first-degree relative dx <65 or multiple at any age): annual PSA, ages 45-69
📋 Non-Black w/ one first-degree relative dx ≥65: every 2 yrs, ages 45-69
🔬 Age-adjusted elevated = PSA ≥3.0 (ages 45-69) or ≥6.5 (70-74); repeat in 2 wks to 3 mo, then MRI and/or validated biomarker before biopsy
🛑 70-74 individualized; not recommended ≥75 or if life expectancy <10 yrs
⚠️ Still requires informed consent on benefits, limits, and harms, and departs from USPSTF’s grade C for 55-69
🎯 ACS has moved from “discuss it” to “do it” for average-risk men 50-69 and high-risk men from 45, its biggest change since 2010
🔗 doi.org/10.3322/caac.70112
@UroOnc @urotoday @UrologyTimes @PCF_Science @AmerUrological
UCLA Urology retweeted
Special morning at @UofUSurgery Grand Rounds: my Northwestern co-resident Dr. Scott Eggener @uroegg , now Chair @UclaUrology on "Dogma, Doubts, and Debunking Myths."
“50% of what we learn in training is wrong. The hard part is knowing which 50%.”
Great to have you in Salt Lake, Scott! #GrandRounds
UCLA Urology retweeted
Excellent talk by Dr. Scott Eggener @uroegg at @UofUHealth challenging surgical dogma. Publication bias, flawed peer review, and entrenched beliefs can turn weak evidence into accepted “truth.”
A powerful reminder that in surgery, no answer should be beyond questioning!
In a previous excerpt, UCLA Health urologist Dr. Juan José Andino discussed research on prostate cancer screening disparities among Hispanic men.
In this new video, he shares a message in Spanish about PSA screening, sexual health, and heart health.
Please share with a Spanish-speaking family member or friend who could benefit. ->
UN MENSAJE IMPORTANTE SOBRE LA SALUD DE LOS HOMBRES
¿Cuándo fue la última vez que hablaste con tu médico sobre tu salud?
El Dr. Juan José Andino, urólogo de UCLA Health, comparte dos mensajes importantes para los hombres y sus familias.
1. CÁNCER DE PRÓSTATA: PREGUNTA POR LA PRUEBA DEL PSA
El PSA (antígeno prostático específico) es un análisis de sangre que puede ayudar a detectar el cáncer de próstata antes de que aparezcan síntomas.
El Dr. Andino anima a los hombres a hablar con su médico sobre esta prueba alrededor de los 40 años. La edad adecuada para comenzar depende del riesgo individual, incluidos los antecedentes familiares.
No todos los hombres necesitan hacerse la prueba a la misma edad. Lo importante es tener la conversación y tomar una decisión informada.
2. DISFUNCIÓN ERÉCTIL: UNA POSIBLE SEÑAL DE ALERTA
Los cambios en las erecciones no siempre son solo un problema sexual. En algunos hombres, pueden ser una señal de problemas cardiovasculares.
No tengas pena de hablarlo. Tu médico puede ayudarte a identificar la causa y conocer las opciones de tratamiento.
TU SALUD IMPORTA. DA EL PASO.
Habla con tu médico, haz preguntas y no esperes a tener síntomas para cuidar tu salud.
Comparte este video con tu papá, hermano, esposo, hijo o amigo. Una conversación puede marcar la diferencia.
CONOCE AL ESPECIALISTA
Juan José Andino, MD, MBA
Urólogo de UCLA Health, especializado en salud del hombre y medicina sexual. También atiende a pacientes en el sur de Los Ángeles.
uclahealth.org/providers/jua…
and on IG: instagram.com/drandinourolog…
SÍGUENOS PARA APRENDER MÁS
Somos parte de @BlueCure, una organización sin fines de lucro dedicada a la educación sobre el cáncer de próstata y la salud masculina. Descarga gratis nuestra lista “Conoce Tus Números” en español para llevarla a tu próxima cita médica: bluecure.org
Visita Instagram.com/bluecureespano… cada semana para encontrar nuevos videos, entrevistas e información en español para ti y tu familia.
Aviso médico: Contenido educativo. No sustituye la consulta médica. Habla con tu médico sobre las pruebas y decisiones adecuadas para ti.
PROSTATE CANCER: A SCREENING GAP FOR HISPANIC MEN
Are Hispanic men being diagnosed with prostate cancer at more advanced stages? Are opportunities for early detection being missed?
In this Blue Cure Men’s Health Podcast excerpt, Juan José Andino, MD, MBA, a UCLA Health urologist specializing in men’s sexual health and prostate cancer, discusses disparities in prostate cancer screening and diagnosis among Hispanic and Latino men.
WHAT THE RESEARCH SHOWS
• 24% higher risk: Research cited in Cancer (2025) found that Hispanic men ages 55–69 had a 24% higher risk of advanced prostate cancer at diagnosis compared with non-Hispanic White men.
• Lower screening rates: National survey data cited in the same research found lower PSA screening rates among Hispanic men (22%) compared with non-Hispanic White men (32%).
• More research is needed: Dr. Andino discusses whether continued evidence of these disparities could support more focused screening recommendations.
WHY THIS MATTERS
A PSA (prostate-specific antigen) blood test can help detect prostate cancer before symptoms develop. An elevated PSA does not automatically mean cancer.
Hispanic and Latino men are not one uniform population. Risk and access to care vary across communities.
TAKE ACTION
Don’t wait for symptoms to discuss prostate health. Ask your doctor when PSA screening makes sense based on your age, family history, and personal risk.
Share this with a father, brother, husband, son, or friend. One conversation could make a difference.
ABOUT OUR GUEST
Juan José Andino, MD, MBA
Urologist | UCLA Health
uclahealth.org/providers/jua…
IG: instagram.com/drandinourolog…
RESEARCH
Noriega Esquives BS, et al. Cancer. 2025.
DOI: 10.1002/cncr.70029
Medical disclaimer: Educational information only, not individualized medical advice. Discuss screening decisions with your healthcare professional.
UCLA Urology retweeted
My good friend and co-fellow from NIH UOB, @KidneyCancerDoc Prof Brian Shuch highlights the importance of alternatives to surgery at the @SUO_YUO fellows course in Cleveland. New technologies such as Histotripsy are being actively explored as future paths!
UCLA Urology retweeted
Last week at the Western Section of the American Urological Association, Yurong Shao, a medical student at the University of Washington, received 1st Place Best of Section in the Prostate Cancer, Pelvic Floor & Voiding Dysfunction session!
Congratulations, Yurong! We’re proud of your achievement and look forward to seeing all that you accomplish in the future!
ED AFTER PROSTATE CANCER TREATMENT: WHAT ARE YOUR OPTIONS?
Erectile dysfunction (ED) after prostate cancer surgery or radiation can affect more than sexual function. It can impact confidence, intimacy, relationships, and quality of life.
Here’s what every man should know: ED is a medical issue, not a personal failure. And treatment options exist.
In this Blue Cure Men’s Health Podcast excerpt, Juan José Andino, MD, MBA, a UCLA Health urologist specializing in men’s sexual health, explains how men can receive support before and after prostate cancer treatment, including when ED pills aren’t enough.
WHAT MEN AND THEIR PARTNERS SHOULD KNOW:
• Prehabilitation (prehab) and rehabilitation: Sexual health care can begin before cancer treatment and continue afterward to help patients prepare, manage side effects, and support recovery.
• Oral medications: Sildenafil (Viagra) and tadalafil (Cialis) may help improve erections, but they don’t work for everyone.
• Vacuum erection devices (VEDs): Use suction to draw blood into the penis to help produce an erection.
• Penile injections (ICI): Medication injected directly into the penis can help produce an erection when pills aren’t effective. Medical guidance is essential.
• Penile implants: Surgically placed devices may help men with persistent ED that hasn’t responded to other treatments.
THERE IS NO SHAME IN ASKING FOR HELP.
Some men assume changes in sexual function are simply something they must accept after cancer treatment. That’s not necessarily true.
Recovery varies, and no single treatment is right for everyone. But you deserve to understand your options.
Ask your urologist about sexual rehabilitation and whether a sexual medicine specialist could help.
LEARN MORE:
Dr. Juan José Andino, UCLA Health:
uclahealth.org/providers/jua…
Share this with someone who may benefit. A conversation could make a difference.
Medical disclaimer: Educational only, not personal medical advice. Discuss treatment options with your healthcare professional.
UCLA Urology retweeted
Should you get a second opinion after a testicular cancer diagnosis?
In today's new episode of It Takes Balls, Dr. Scott Eggener of @UCLAHealth discusses second opinions, overtreatment, and informed treatment decisions.
🎧 Listen: testicularcancerawarenessfou…
#testicularcancer





































